Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

for
Autoimmune Encephalitis, Encephalitis
Location: Boston MA, New Haven CT, Brooklyn NY, New York NY,
Sponsor: University of Utah

Sex: All

Age: 12+

Code: NCT04372615

Phase2, Recruiting

COVID-19 Coagulopathy Extension Study

for
COVID-19
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 18 - 70+

Code: NCT05334615

Recruiting

Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

for
Solid Tumor
Location: Pittsburgh PA, Edgewood KY, Iowa City IA, Phoenix AZ
Sponsor: Oxford BioTherapeutics Ltd

Sex: All

Age: 18+

Code: NCT04064359

Phase1, Recruiting

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

for
Sensorineural Hearing Loss, Bilateral
Location: Boston MA, Philadelphia PA, Toronto, Cincinnati OH,
Sponsor: Akouos, Inc.

Sex: All

Age: 0+

Code: NCT05821959

Phase1, Phase2, Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Boston MA, New Haven CT, New York NY,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

for
Gestational Diabetes
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: Female

Age: 18 - 45

Code: NCT05917587

Early_phase1, Recruiting

Patient-driven Management of BP in CKD

for
Chronic Kidney Disease
Location: Iowa City IA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05546099

Phase3, Recruiting

Test-retest Evaluation of [18F]F-AraG PET

for
Non-small Cell Lung Cancer
Location: Iowa City IA
Sponsor: CellSight Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06084806

Phase2, Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase1, Recruiting

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

for
Breast Neoplasm Female
Location: Madison WI, Iowa City IA
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18+

Code: NCT03096418

Recruiting

Oxytocin and Fetal Heart Rate Changes

for
Fetal Bradycardia Complicating Labor and Delivery,
Location: Iowa City IA
Sponsor: Unyime Ituk

Sex: Female

Age: 18 - 55

Code: NCT03232918

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Baltimore MD, Fairfax VA, Chapel Hill NC, Miami FL,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase1, Phase2, Recruiting

Subthalamic Nucleus Deep Brain Stimulation in Speech Study

for
Parkinson Disease, Dysarthria
Location: Iowa City IA
Sponsor: Jeremy Greenlee

Sex: All

Age: 21 - 70+

Code: NCT05493670

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Richmond VA, Webster NY, Rochester NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

for
Cystic Fibrosis
Location: Boston MA, Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center

Sex: All

Age: 3 - 18

Code: NCT06654752

Recruiting

Cochlear Implant Speech in Noise Processing

for
Hearing Loss, Adult-Onset, Speech Intelligibility,
Location: Iowa City IA
Sponsor: Craig D. Workman, PhD

Sex: All

Age: 18 - 70+

Code: NCT06860152

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Boston MA, Baltimore MD, Bethesda MD, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

for
Myotonic Dystrophy 1, DM1
Location: Richmond VA, Rochester NY, Gainesville FL, Columbus OH,
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18 - 70

Code: NCT03981575

Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase1, Phase2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Norwich CT, Hackensack NJ, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa